Evaluation of the efficacy of levocarnitine in supporting therapy in multiple myeloma

Achilova , Ozoda, Makhamadalieva, Gulchekhra, Iskhakov, Eldor, Ачилова, Озода, Махамадалиева , Гульчехра, Исхаков, Эльдор, Achilova, Ozoda, Mahamadalieva, Gulchehra, Ishakov, Eldor

Жамият ва инновациялар / Общество и инновации / Society and innovations · 2021-yil

Annotatsiya

The accompanying therapy prescribed during the use of toxic drugs helps patients to complete the treatment to the end, and the doctor adheres to the treatment of the chosen line The aim of the study was to study the effect of levocarnitine on blood biochemical parameters and on chemotherapy tolerance. Materials and methods. The study was conducted in the stem cell treatment department at Republican Specialized Scientific Practical Medical Center of Hematology . Chemotherapy toxicity was assessed according to WHO and NCIC standards. Results. In a comparative study, 30 patients receiving chemotherapy for myeloma with varying degrees of toxicity when fortecarnite (100 mg / kg / day) was added to standard therapy for 2 months or more showed a significant positive change in cytochemical parameters (Alanin transferase (ALT), aspartat transferase (AST)), which allowed the authors recommend metabolic correction to all patients receiving chemotherapy, especially with 2nd and 3rd degree of toxicity.

Maqola ma’lumotlari
MualliflarAchilova , Ozoda, Makhamadalieva, Gulchekhra, Iskhakov, Eldor, Ачилова, Озода, Махамадалиева , Гульчехра, Исхаков, Эльдор, Achilova, Ozoda, Mahamadalieva, Gulchehra, Ishakov, Eldor
JurnalЖамият ва инновациялар / Общество и инновации / Society and innovations
NashriyotIn Science МЧЖ
ISSN2181-1415
Nashr sanasi2021-03-09
Jild2
Son1
Betlar56-61
TilIngliz
Ilmiy sohaTibbiyot
DOI10.47689/2181-1415-vol2-iss1-pp56-61
Indeksga qo‘shilgan2026-08-26

DOI: 10.47689/2181-1415-vol2-iss1-pp56-61 · Maqolaning asl sahifasi

Kalit so‘zlar

accompanying therapy, levocarnitine, toxicity assessment, fortecarnitis, metabolic correction., сопроводительная терапия, левокарнитин, оценка токсичности, фортекарнит, метаболическая коррекция., qo'shma terapiya, levokarnitin, toksikani baholash, fortekarnit, metabolik tuzatish.

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAAchilova , Ozoda, Makhamadalieva, Gulchekhra, Iskhakov, Eldor, Ачилова, Озода, Махамадалиева , Гульчехра, Исхаков, Эльдор, Achilova, Ozoda, Mahamadalieva, Gulchehra, & Ishakov, Eldor (2021). Evaluation of the efficacy of levocarnitine in supporting therapy in multiple myeloma. Жамият ва инновациялар / Общество и инновации / Society and innovations, 2(1), 56-61. https://doi.org/10.47689/2181-1415-vol2-iss1-pp56-61
GOST (OAK)Achilova , Ozoda va b. Evaluation of the efficacy of levocarnitine in supporting therapy in multiple myeloma // Жамият ва инновациялар / Общество и инновации / Society and innovations. – 2021. – T. 2, № 1. – P. 56-61. – DOI: 10.47689/2181-1415-vol2-iss1-pp56-61.
MLAAchilova , Ozoda, Makhamadalieva, Gulchekhra, Iskhakov, Eldor, Ачилова, Озода, Махамадалиева , Гульчехра, Исхаков, Эльдор, Achilova, Ozoda, Mahamadalieva, Gulchehra, and Ishakov, Eldor. “Evaluation of the efficacy of levocarnitine in supporting therapy in multiple myeloma.” Жамият ва инновациялар / Общество и инновации / Society and innovations, 2(1), 56-61, 2021. https://doi.org/10.47689/2181-1415-vol2-iss1-pp56-61
ChicagoAchilova , Ozoda, Makhamadalieva, Gulchekhra, Iskhakov, Eldor, Ачилова, Озода, Махамадалиева , Гульчехра, Исхаков, Эльдор, Achilova, Ozoda, Mahamadalieva, Gulchehra, and Ishakov, Eldor. “Evaluation of the efficacy of levocarnitine in supporting therapy in multiple myeloma.” Жамият ва инновациялар / Общество и инновации / Society and innovations, 2(1), 56-61 (2021). https://doi.org/10.47689/2181-1415-vol2-iss1-pp56-61
HarvardAchilova , Ozoda, Makhamadalieva, Gulchekhra, Iskhakov, Eldor, Ачилова, Озода, Махамадалиева , Гульчехра, Исхаков, Эльдор, Achilova, Ozoda, Mahamadalieva, Gulchehra, and Ishakov, Eldor (2021) ‘Evaluation of the efficacy of levocarnitine in supporting therapy in multiple myeloma’, Жамият ва инновациялар / Общество и инновации / Society and innovations, 2(1), 56-61. https://doi.org/10.47689/2181-1415-vol2-iss1-pp56-61
BibTeX
@article{achilovaozoda2021,
  title = {Evaluation of the efficacy of levocarnitine in supporting therapy in multiple myeloma},
  author = {Achilova , Ozoda and Makhamadalieva, Gulchekhra and Iskhakov, Eldor and Ачилова, Озода and Махамадалиева , Гульчехра and Исхаков, Эльдор and Achilova, Ozoda and Mahamadalieva, Gulchehra and Ishakov, Eldor},
  journal = {Жамият ва инновациялар / Общество и инновации / Society and innovations},
  year = {2021},
  volume = {2},
  number = {1},
  pages = {56-61},
  doi = {10.47689/2181-1415-vol2-iss1-pp56-61},
  url = {https://doi.org/10.47689/2181-1415-vol2-iss1-pp56-61}
}

Boshqa maqola uchun iqtibos tayyorlash

Жамият ва инновациялар / Общество и инновации / Society and innovations jurnalidan boshqa maqolalar

Жамият ва инновациялар / Общество и инновации / Society and innovations — barcha maqolalar · 2021-yil arxivi

Achilova , Ozoda — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari